3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
37
Myelodysplastic Syndromes
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Leukemia
11
Hematologic Neoplasms
10
Lymphoma
9
Hodgkin Disease
9
Anemia, Refractory, with Excess of Blasts
9
Myeloproliferative Disorders
8
Multiple Myeloma
8
Lymphoma, Non-Hodgkin
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Graft vs Host Disease
7
Leukemia, Lymphocytic, Chronic, B-Cell
6
Primary Myelofibrosis
5
Neuroblastoma
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Myeloid
4
Congenital Abnormalities
4
Anemia, Aplastic
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Polycythemia Vera
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Paclitaxel
4
Cyclophosphamide
4
exemestane
3
Taxes
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Anastrozole
3
Trastuzumab
2
Leuprolide
2
Immunotherapy
2
Goserelin
2
Carboplatin
2
trastuzumab biosimilar HLX02
1
ribociclib
1
pegfilgrastim
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Vitamins
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Omeprazole
1
Ogivri
1
Neoadjuvant Therapy
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Busulfan
×
1 year
×
Clear all
No trials found.